Evidence map›Paper›PMID 18261192›Full record

SynthesisAddiction (Abingdon, England)2008

Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs).

Kenneth R Conner, Martin Pinquart, Paul R Duberstein

Open access · greenAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Addiction (Abingdon, England), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. The moderating effects of group cognitive-behavioral therapy for depression among substance users.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2012
    Trial
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Kenneth R ConnerUniversity of Rochester Medical Center, Psychiatry, Rochester, NY 14642, USA. kenneth_conner@urmc.rochester.edu
Martin Pinquart
Paul R Duberstein
University of Rochester Medical Center · USPhilipps University of Marburg · DE

Funding

Suicide Research and Prevention MHREGR25MH068564 · NIMH · UNIVERSITY OF ROCHESTER · PI CAINE, ERIC D. · 2003 to 2007
$1.2M
Attempted Suicide and Alcohol DependenceR01AA016149 · NIAAA · UNIVERSITY OF ROCHESTER · PI CONNER, KENNETH R · 2006 to 2009
$1.2M
LLD Course & Treatment Decisions: Psychosocial InfluencesK24MH072712 · NIMH · UNIVERSITY OF ROCHESTER · PI DUBERSTEIN, PAUL R · 2006 to 2010
$722k
NIAAA NIH HHS R01 AA016149NIAAA NIH HHS R01AA016149NIMH NIH HHS K24 MH072712NIMH NIH HHS K24MH072712NIMH NIH HHS R25 MH068564NIMH NIH HHS R25 MH68564
6 · The paper itself

Abstract

aimsTo evaluate, among intravenous drug users (IDUs), the hypothesized positive association of depression with substance-related behaviors including concurrent drug use and impairment, future drug use and impairment, alcohol use and impairment, needle sharing and substance use treatment participation, and to identify moderators of these associations.

designMeta-analysis of reports on IDUs published in English in peer-reviewed journals since 1986 that contained data on depression and substance use outcome(s) with no restrictions on range of depression scores to select the sample.

settingFifty-five reports containing 55 samples met criteria, including 42 (76%) samples from clinical venues and 13 (24%) that were community-based.

participantsMean age was 34.3 (standard deviation = 4.5) years, comprising approximately 68% men and 43% white, non-Hispanic subjects. MEASUREMENTS: Depression was assessed with the Beck Depression Inventory, Center for Epidemiological Studies Depression Scale (CES-D) and other validated scales or diagnostic interviews. The Addiction Severity Index was the most frequently used measure of substance-related outcomes.

findingsA priori hypotheses pertaining to depression and the substance-related variables were supported, with the exception of the predicted association of depression and future drug use and impairment. Effect sizes were small. Moderating effects of gender were identified, including greater associations of depression with substance use treatment participation and needle sharing among women and a greater association of depression with future drug use and impairment among men. Effect sizes of moderators were large.

conclusionsDepression is associated with several substance-related behaviors, and select associations are stronger according to gender. Prospective associations of depression with future drug use and impairment are not immediately evident, but could be examined in subsequent research.

Indexed as

AdultDepressive DisorderFemaleHumansMaleNeedle SharingSubstance Abuse, Intravenous

Identifiers

PMID18261192
PMCPMC4864591
OpenAlexW1977711906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.